Corona (5909) 주식 개요코로나 코퍼레이션은 일본에서 등유 난방 기기를 제조 및 판매하는 회사입니다. 자세히 보기5909 펀더멘털 분석스노우플레이크 점수가치 평가0/6미래 성장0/6과거 실적2/6재무 건전성6/6배당2/6위험 분석3.02%의 배당금은 수익이나 자유현금흐름으로 잘 충당되지 않습니다.모든 위험 점검 보기5909 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueJP¥Current PriceJP¥926.0034.0% 고평가 내재 할인율Growth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture092b2016201920222025202620282031Revenue JP¥91.8bEarnings JP¥1.1bAdvancedSet Fair ValueView all narrativesCorona Corporation 경쟁사CleanupSymbol: TSE:7955Market cap: JP¥30.2bJANOMESymbol: TSE:6445Market cap: JP¥20.0bNihon TrimSymbol: TSE:6788Market cap: JP¥32.0bDainichiSymbol: TSE:5951Market cap: JP¥13.9b가격 이력 및 성과Corona 주가의 최고가, 최저가 및 변동 요약과거 주가현재 주가JP¥926.0052주 최고가JP¥1,110.0052주 최저가JP¥866.00베타0.341개월 변동-4.93%3개월 변동-11.05%1년 변동3.81%3년 변동4.28%5년 변동-0.54%IPO 이후 변동-56.74%최근 뉴스 및 업데이트Reported Earnings • May 13Full year 2026 earnings released: EPS: JP¥33.90 (vs JP¥37.77 in FY 2025)Full year 2026 results: EPS: JP¥33.90 (down from JP¥37.77 in FY 2025). Revenue: JP¥85.3b (flat on FY 2025). Net income: JP¥991.0m (down 10% from FY 2025). Profit margin: 1.2% (down from 1.3% in FY 2025). Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.공시 • May 12Corona Corporation, Annual General Meeting, Jun 24, 2026Corona Corporation, Annual General Meeting, Jun 24, 2026.공시 • May 10Corona Corporation to Report Fiscal Year 2026 Results on May 12, 2026Corona Corporation announced that they will report fiscal year 2026 results on May 12, 2026Upcoming Dividend • Mar 23Upcoming dividend of JP¥14.00 per shareEligible shareholders must have bought the stock before 30 March 2026. Payment date: 29 June 2026. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 2.9%. Lower than top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (1.6%).Reported Earnings • Feb 05Third quarter 2026 earnings released: EPS: JP¥60.52 (vs JP¥59.57 in 3Q 2025)Third quarter 2026 results: EPS: JP¥60.52 (up from JP¥59.57 in 3Q 2025). Revenue: JP¥29.0b (flat on 3Q 2025). Net income: JP¥1.77b (up 1.7% from 3Q 2025). Profit margin: 6.1% (up from 6.0% in 3Q 2025). Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.분석 기사 • Dec 18Corona (TSE:5909) Is Paying Out A Dividend Of ¥14.00The board of Corona Corporation ( TSE:5909 ) has announced that it will pay a dividend on the 29th of June, with...더 많은 업데이트 보기Recent updatesReported Earnings • May 13Full year 2026 earnings released: EPS: JP¥33.90 (vs JP¥37.77 in FY 2025)Full year 2026 results: EPS: JP¥33.90 (down from JP¥37.77 in FY 2025). Revenue: JP¥85.3b (flat on FY 2025). Net income: JP¥991.0m (down 10% from FY 2025). Profit margin: 1.2% (down from 1.3% in FY 2025). Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.공시 • May 12Corona Corporation, Annual General Meeting, Jun 24, 2026Corona Corporation, Annual General Meeting, Jun 24, 2026.공시 • May 10Corona Corporation to Report Fiscal Year 2026 Results on May 12, 2026Corona Corporation announced that they will report fiscal year 2026 results on May 12, 2026Upcoming Dividend • Mar 23Upcoming dividend of JP¥14.00 per shareEligible shareholders must have bought the stock before 30 March 2026. Payment date: 29 June 2026. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 2.9%. Lower than top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (1.6%).Reported Earnings • Feb 05Third quarter 2026 earnings released: EPS: JP¥60.52 (vs JP¥59.57 in 3Q 2025)Third quarter 2026 results: EPS: JP¥60.52 (up from JP¥59.57 in 3Q 2025). Revenue: JP¥29.0b (flat on 3Q 2025). Net income: JP¥1.77b (up 1.7% from 3Q 2025). Profit margin: 6.1% (up from 6.0% in 3Q 2025). Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.분석 기사 • Dec 18Corona (TSE:5909) Is Paying Out A Dividend Of ¥14.00The board of Corona Corporation ( TSE:5909 ) has announced that it will pay a dividend on the 29th of June, with...공시 • Dec 17Corona Corporation to Report Q3, 2026 Results on Feb 04, 2026Corona Corporation announced that they will report Q3, 2026 results on Feb 04, 2026분석 기사 • Dec 04Corona's (TSE:5909) Dividend Will Be ¥14.00Corona Corporation's ( TSE:5909 ) investors are due to receive a payment of ¥14.00 per share on 29th of June. This...Declared Dividend • Dec 04First half dividend of JP¥14.00 announcedDividend of JP¥14.00 is the same as last year. Ex-date: 30th March 2026 Payment date: 29th June 2026 Dividend yield will be 2.9%, which is higher than the industry average of 1.6%. Sustainability & Growth Dividend is not covered by earnings (117% earnings payout ratio) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. The company's earnings per share (EPS) would need to grow by 29% to bring the payout ratio under control, which is more than the 14% EPS growth achieved over the last 5 years.Reported Earnings • Oct 31Second quarter 2026 earnings released: EPS: JP¥9.34 (vs JP¥11.30 in 2Q 2025)Second quarter 2026 results: EPS: JP¥9.34 (down from JP¥11.30 in 2Q 2025). Revenue: JP¥21.3b (flat on 2Q 2025). Net income: JP¥273.0m (down 17% from 2Q 2025). Profit margin: 1.3% (down from 1.6% in 2Q 2025). Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings.Upcoming Dividend • Sep 22Upcoming dividend of JP¥14.00 per shareEligible shareholders must have bought the stock before 29 September 2025. Payment date: 03 December 2025. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 2.9%. Lower than top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (1.4%).분석 기사 • Sep 19Corona (TSE:5909) Has Announced A Dividend Of ¥14.00Corona Corporation ( TSE:5909 ) will pay a dividend of ¥14.00 on the 3rd of December. This makes the dividend yield...분석 기사 • Sep 03Corona's (TSE:5909) Dividend Will Be ¥14.00Corona Corporation ( TSE:5909 ) will pay a dividend of ¥14.00 on the 3rd of December. The dividend yield will be 3.0...공시 • Sep 02Corona Corporation to Report Q2, 2026 Results on Oct 30, 2025Corona Corporation announced that they will report Q2, 2026 results on Oct 30, 2025New Risk • Aug 06New major risk - Dividend sustainabilityThe dividend is not well covered by earnings and cash flows. Payout ratio: 108% The company is paying a dividend despite having no free cash flows. Dividend yield: 2.9% This is considered a major risk. Companies that pay out too much of their earnings and cash flows are at risk of having to reduce or cut their dividend in future. If earnings or cash flows stagnate or fall, then there may not be enough to maintain the same dividend. Or in extreme cases, companies may opt to dig into capital reserves or take on debt to maintain the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Payout ratio: 108% Paying a dividend despite having no free cash flows. Minor Risk Profit margins are more than 30% lower than last year (0.9% net profit margin).Reported Earnings • Jul 31First quarter 2026 earnings released: JP¥18.21 loss per share (vs JP¥6.44 loss in 1Q 2025)First quarter 2026 results: JP¥18.21 loss per share (further deteriorated from JP¥6.44 loss in 1Q 2025). Revenue: JP¥18.9b (flat on 1Q 2025). Net loss: JP¥532.0m (loss widened 183% from 1Q 2025). Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings.분석 기사 • Jul 24Corona's (TSE:5909) Dividend Will Be ¥14.00The board of Corona Corporation ( TSE:5909 ) has announced that it will pay a dividend of ¥14.00 per share on the 3rd...분석 기사 • Jul 10Corona (TSE:5909) Is Due To Pay A Dividend Of ¥14.00Corona Corporation ( TSE:5909 ) has announced that it will pay a dividend of ¥14.00 per share on the 3rd of December...Declared Dividend • Jul 09Final dividend of JP¥14.00 announcedDividend of JP¥14.00 is the same as last year. Ex-date: 29th September 2025 Payment date: 3rd December 2025 Dividend yield will be 3.0%, which is higher than the industry average of 1.6%. Sustainability & Growth Dividend is covered by earnings (72% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 23% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.공시 • Jun 27Corona Corporation to Report Q1, 2026 Results on Jul 30, 2025Corona Corporation announced that they will report Q1, 2026 results on Jul 30, 2025Reported Earnings • May 10Full year 2025 earnings released: EPS: JP¥37.77 (vs JP¥44.74 in FY 2024)Full year 2025 results: EPS: JP¥37.77 (down from JP¥44.74 in FY 2024). Revenue: JP¥85.2b (up 3.9% from FY 2024). Net income: JP¥1.10b (down 16% from FY 2024). Profit margin: 1.3% (down from 1.6% in FY 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 2% per year whereas the company’s share price has increased by 4% per year.공시 • May 09Corona Corporation, Annual General Meeting, Jun 26, 2025Corona Corporation, Annual General Meeting, Jun 26, 2025.분석 기사 • Mar 22Corona (TSE:5909) Has Affirmed Its Dividend Of ¥14.00Corona Corporation ( TSE:5909 ) has announced that it will pay a dividend of ¥14.00 per share on the 26th of June...공시 • Mar 22Corona Corporation to Report Fiscal Year 2025 Results on May 09, 2025Corona Corporation announced that they will report fiscal year 2025 results on May 09, 2025Upcoming Dividend • Mar 21Upcoming dividend of JP¥14.00 per shareEligible shareholders must have bought the stock before 28 March 2025. Payment date: 26 June 2025. Payout ratio is a comfortable 72% but the company is not cash flow positive. Trailing yield: 2.8%. Lower than top quartile of Japanese dividend payers (3.7%). Higher than average of industry peers (1.5%).분석 기사 • Feb 10Corona (TSE:5909) Is Due To Pay A Dividend Of ¥14.00The board of Corona Corporation ( TSE:5909 ) has announced that it will pay a dividend on the 26th of June, with...Reported Earnings • Feb 06Third quarter 2025 earnings released: EPS: JP¥59.57 (vs JP¥69.50 in 3Q 2024)Third quarter 2025 results: EPS: JP¥59.57 (down from JP¥69.50 in 3Q 2024). Revenue: JP¥29.0b (down 3.8% from 3Q 2024). Net income: JP¥1.74b (down 14% from 3Q 2024). Profit margin: 6.0% (down from 6.7% in 3Q 2024). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.분석 기사 • Dec 20Corona (TSE:5909) Has Announced A Dividend Of ¥14.00Corona Corporation ( TSE:5909 ) has announced that it will pay a dividend of ¥14.00 per share on the 26th of June. This...공시 • Dec 20Corona Corporation to Report Q3, 2025 Results on Feb 04, 2025Corona Corporation announced that they will report Q3, 2025 results on Feb 04, 2025분석 기사 • Dec 04Corona (TSE:5909) Is Due To Pay A Dividend Of ¥14.00Corona Corporation's ( TSE:5909 ) investors are due to receive a payment of ¥14.00 per share on 26th of June. The...Declared Dividend • Dec 04First half dividend of JP¥14.00 announcedDividend of JP¥14.00 is the same as last year. Ex-date: 28th March 2025 Payment date: 26th June 2025 Dividend yield will be 2.9%, which is higher than the industry average of 1.6%. Sustainability & Growth Dividend is covered by earnings (29% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 4.3% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.Reported Earnings • Nov 01Second quarter 2025 earnings released: EPS: JP¥11.30 (vs JP¥7.80 in 2Q 2024)Second quarter 2025 results: EPS: JP¥11.30 (up from JP¥7.80 in 2Q 2024). Revenue: JP¥21.3b (up 10.0% from 2Q 2024). Net income: JP¥330.0m (up 45% from 2Q 2024). Profit margin: 1.6% (up from 1.2% in 2Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.분석 기사 • Sep 24Corona (TSE:5909) Has Announced A Dividend Of ¥14.00Corona Corporation's ( TSE:5909 ) investors are due to receive a payment of ¥14.00 per share on 4th of December. The...Upcoming Dividend • Sep 20Upcoming dividend of JP¥14.00 per shareEligible shareholders must have bought the stock before 27 September 2024. Payment date: 04 December 2024. Payout ratio is a comfortable 61% but the company is not cash flow positive. Trailing yield: 2.9%. Lower than top quartile of Japanese dividend payers (3.8%). Higher than average of industry peers (1.8%).분석 기사 • Aug 29Corona (TSE:5909) Will Pay A Dividend Of ¥14.00The board of Corona Corporation ( TSE:5909 ) has announced that it will pay a dividend on the 4th of December, with...공시 • Aug 28Corona Corporation to Report Q2, 2025 Results on Oct 30, 2024Corona Corporation announced that they will report Q2, 2025 results on Oct 30, 2024분석 기사 • Aug 09Corona (TSE:5909) Is Due To Pay A Dividend Of ¥14.00The board of Corona Corporation ( TSE:5909 ) has announced that it will pay a dividend of ¥14.00 per share on the 4th...Reported Earnings • Aug 01First quarter 2025 earnings released: JP¥6.44 loss per share (vs JP¥7.27 loss in 1Q 2024)First quarter 2025 results: JP¥6.44 loss per share (improved from JP¥7.27 loss in 1Q 2024). Revenue: JP¥18.9b (up 5.5% from 1Q 2024). Net loss: JP¥188.0m (loss narrowed 11% from 1Q 2024). Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth.공시 • Jul 30+ 1 more updateCorona Corporation Provides Consolidated Earnings Guidance for Period Ending September 2024 and for Year Ending March 2025Corona Corporation provided consolidated earnings guidance for period ending September 2024 and for year ending March 2025. For the period, the company expected net sales of JPY 39,200 million, operating loss of JPY 500 million, loss attributable to owners of parent of JPY 300 million, Basic loss per share of JPY 10.28 per basic share. For the year 2025, the company expected net sales of JPY 85,000 million, operating profit of JPY 1,300 million, profit attributable to owners of parent of JPY 1,200 million, Basic earnings per share of JPY 41.10 per basic share.분석 기사 • Jul 26Corona (TSE:5909) Has Announced A Dividend Of ¥14.00The board of Corona Corporation ( TSE:5909 ) has announced that it will pay a dividend on the 4th of December, with...분석 기사 • Jul 12Corona's (TSE:5909) Dividend Will Be ¥14.00Corona Corporation's ( TSE:5909 ) investors are due to receive a payment of ¥14.00 per share on 4th of December. The...Declared Dividend • Jul 11Final dividend of JP¥14.00 announcedDividend of JP¥14.00 is the same as last year. Ex-date: 27th September 2024 Payment date: 4th December 2024 Dividend yield will be 2.9%, which is higher than the industry average of 1.6%. Sustainability & Growth Dividend is not covered by earnings (102% earnings payout ratio) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to grow by 13% to bring the payout ratio under control, which is more than the 1.0% EPS growth achieved over the last 5 years.공시 • Jun 27Corona Corporation to Report Q1, 2025 Results on Jul 30, 2024Corona Corporation announced that they will report Q1, 2025 results on Jul 30, 2024Reported Earnings • May 12Full year 2024 earnings released: EPS: JP¥44.74 (vs JP¥50.81 in FY 2023)Full year 2024 results: EPS: JP¥44.74 (down from JP¥50.81 in FY 2023). Revenue: JP¥82.0b (down 3.9% from FY 2023). Net income: JP¥1.31b (down 12% from FY 2023). Profit margin: 1.6% (down from 1.7% in FY 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.공시 • May 12Corona Corporation, Annual General Meeting, Jun 25, 2024Corona Corporation, Annual General Meeting, Jun 25, 2024.분석 기사 • Mar 25Corona (TSE:5909) Has Announced A Dividend Of ¥14.00Corona Corporation ( TSE:5909 ) has announced that it will pay a dividend of ¥14.00 per share on the 1st of July. This...공시 • Mar 23Corona Corporation to Report Fiscal Year 2024 Results on May 10, 2024Corona Corporation announced that they will report fiscal year 2024 results on May 10, 2024Upcoming Dividend • Mar 21Upcoming dividend of JP¥14.00 per shareEligible shareholders must have bought the stock before 28 March 2024. Payment date: 01 July 2024. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 2.8%. Lower than top quartile of Japanese dividend payers (3.2%). Higher than average of industry peers (1.6%).Reported Earnings • Feb 04Third quarter 2024 earnings released: EPS: JP¥69.50 (vs JP¥65.42 in 3Q 2023)Third quarter 2024 results: EPS: JP¥69.50 (up from JP¥65.42 in 3Q 2023). Revenue: JP¥30.1b (up 2.0% from 3Q 2023). Net income: JP¥2.03b (up 6.3% from 3Q 2023). Profit margin: 6.7% (up from 6.5% in 3Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.공시 • Feb 02+ 1 more updateCorona Corporation Provides Dividend Guidance for the Full Year Ending March 31, 2024Corona Corporation provided dividend guidance of JPY 14.00 for the full year ending March 31, 2024.공시 • Dec 16Corona Corporation to Report Q3, 2024 Results on Feb 02, 2024Corona Corporation announced that they will report Q3, 2024 results on Feb 02, 2024공시 • Nov 02Corona Corporation (TSE:5909) announces an Equity Buyback for 80,000 shares, representing 0.27% for ¥75 million.Corona Corporation (TSE:5909) announces an share repurchase program. Under the program the company will repurchase 80,000 shares, representing 0.27% of its issued share capital, for ¥75 million. The purpose of the program is to enable the implementation of a flexible capital policy in response to changes in the business environment. The program is valid till November 16, 2023. As of October 31, 2023, the company had 29,226,249 issued shares (excluding treasury stock) and 116,205 shares in treasury.Buying Opportunity • Oct 04Now 21% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be JP¥1,149, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 56%.Upcoming Dividend • Sep 21Upcoming dividend of JP¥14.00 per share at 3.0% yieldEligible shareholders must have bought the stock before 28 September 2023. Payment date: 04 December 2023. Payout ratio is a comfortable 62% and this is well supported by cash flows. Trailing yield: 3.0%. Lower than top quartile of Japanese dividend payers (3.3%). Higher than average of industry peers (1.6%).공시 • Sep 16Corona Corporation to Report Q2, 2024 Results on Oct 31, 2023Corona Corporation announced that they will report Q2, 2024 results on Oct 31, 2023Reported Earnings • Jul 29First quarter 2024 earnings released: JP¥7.27 loss per share (vs JP¥1.72 loss in 1Q 2023)First quarter 2024 results: JP¥7.27 loss per share (further deteriorated from JP¥1.72 loss in 1Q 2023). Revenue: JP¥17.9b (down 7.5% from 1Q 2023). Net loss: JP¥212.0m (loss widened 324% from 1Q 2023). Over the last 3 years on average, earnings per share has increased by 56% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.공시 • Jun 28Corona Corporation to Report Q1, 2024 Results on Jul 28, 2023Corona Corporation announced that they will report Q1, 2024 results on Jul 28, 2023Reported Earnings • May 12Full year 2023 earnings released: EPS: JP¥50.81 (vs JP¥32.25 in FY 2022)Full year 2023 results: EPS: JP¥50.81 (up from JP¥32.25 in FY 2022). Revenue: JP¥85.3b (up 8.5% from FY 2022). Net income: JP¥1.48b (up 58% from FY 2022). Profit margin: 1.7% (up from 1.2% in FY 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 60% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.공시 • May 11Corona Corporation, Annual General Meeting, Jun 28, 2023Corona Corporation, Annual General Meeting, Jun 28, 2023.Upcoming Dividend • Mar 23Upcoming dividend of JP¥14.00 per share at 3.1% yieldEligible shareholders must have bought the stock before 30 March 2023. Payment date: 29 June 2023. Payout ratio is a comfortable 24% and this is well supported by cash flows. Trailing yield: 3.1%. Lower than top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (1.8%).Reported Earnings • Feb 04Third quarter 2023 earnings released: EPS: JP¥65.42 (vs JP¥47.58 in 3Q 2022)Third quarter 2023 results: EPS: JP¥65.42 (up from JP¥47.58 in 3Q 2022). Revenue: JP¥29.5b (up 12% from 3Q 2022). Net income: JP¥1.91b (up 38% from 3Q 2022). Profit margin: 6.5% (up from 5.2% in 3Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.공시 • Dec 08Corona Corporation to Report Q3, 2023 Results on Feb 03, 2023Corona Corporation announced that they will report Q3, 2023 results on Feb 03, 2023Board Change • Nov 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 9 highly experienced directors. No independent directors (9 non-independent directors). Vice-President, Executive Officer and Representative Director Kazuyoshi Kobayashi was the last director to join the board, commencing their role in 2015. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Reported Earnings • Nov 03Second quarter 2023 earnings released: EPS: JP¥15.77 (vs JP¥11.64 in 2Q 2022)Second quarter 2023 results: EPS: JP¥15.77 (up from JP¥11.64 in 2Q 2022). Revenue: JP¥20.6b (up 2.8% from 2Q 2022). Net income: JP¥460.0m (up 36% from 2Q 2022). Profit margin: 2.2% (up from 1.7% in 2Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.공시 • Nov 02Corona Corporation Provides Consolidated Earnings Guidance for Year Ending March 2023Corona Corporation provided consolidated earnings guidance for year ending March 2023. For the period, the company expected net sales of JPY 82,700 million, operating profit of JPY 1,200 million, profit attributable to owners of parent of JPY 1,000 million, Basic earnings per share of JPY 34.34 per basic share.공시 • Nov 01Corona Corporation Announces Dividend for the Second Quarter of Fiscal Year Ending March 2023, Payable on December 2, 2022; Announces Dividend Guidance for Year Ending March 2023Corona Corporation announced dividend of JPY 14 per share for the second quarter of fiscal year ending March 2023. Dividend payable date (as planned) is December 2, 2022. For the year the company expects to pay the dividend of JPY 14 per share.Upcoming Dividend • Sep 22Upcoming dividend of JP¥14.00 per shareEligible shareholders must have bought the stock before 29 September 2022. Payment date: 02 December 2022. Payout ratio is on the higher end at 79%, however this is supported by cash flows. Trailing yield: 3.3%. Lower than top quartile of Japanese dividend payers (3.7%). Higher than average of industry peers (1.9%).공시 • Sep 01Corona Corporation to Report Q2, 2023 Results on Nov 01, 2022Corona Corporation announced that they will report Q2, 2023 results on Nov 01, 2022Reported Earnings • Jul 31First quarter 2023 earnings released: JP¥1.72 loss per share (vs JP¥4.98 loss in 1Q 2022)First quarter 2023 results: JP¥1.72 loss per share (up from JP¥4.98 loss in 1Q 2022). Revenue: JP¥19.3b (up 6.9% from 1Q 2022). Net loss: JP¥50.0m (loss narrowed 66% from 1Q 2022). Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings.공시 • Jul 29+ 1 more updateCorona Corporation Announces Dividend for the Second Quarter Ended September 30, 2022; Provides Dividend Guidance for the Year Ending December 31, 2022Corona Corporation announced a dividend of ¥14.00 per share for the second quarter ended September 30, 2022, against ¥14.00 per share paid a year ago.For the year ending December 31, 2022, the company expects a dividend of ¥14.00 per share against ¥14.00 per share paid a year ago.공시 • Jun 29Corona Corporation to Report Q1, 2023 Results on Jul 29, 2022Corona Corporation announced that they will report Q1, 2023 results on Jul 29, 2022공시 • May 12+ 1 more updateCorona Corporation Announces Dividend for the Year Ended March 2022, Payable on June 29, 2022; Provides Dividend Guidance for the Second Quarter of Fiscal Year March 2023 and Year End March 2023Corona Corporation announced dividend of JPY 14.00 per share for the year ended March 2022 as compared to paid dividend of JPY 14.00 per share a year ago. Dividend payable date (as planned) June 29, 2022. For the second quarter of fiscal year March 2023, the company expected dividend to be JPY 14.00 per share.For the year end March 2023, the company expected dividend to be JPY 14.00 per share.Reported Earnings • May 11Full year 2022 earnings released: EPS: JP¥32.25 (vs JP¥21.46 in FY 2021)Full year 2022 results: EPS: JP¥32.25 (up from JP¥21.46 in FY 2021). Revenue: JP¥78.6b (down 4.3% from FY 2021). Net income: JP¥939.0m (up 50% from FY 2021). Profit margin: 1.2% (up from 0.8% in FY 2021). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 9% per year whereas the company’s share price has fallen by 6% per year.공시 • May 10Corona Corporation, Annual General Meeting, Jun 28, 2022Corona Corporation, Annual General Meeting, Jun 28, 2022.Board Change • Apr 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 8 highly experienced directors. No independent directors (8 non-independent directors). Vice-President, Executive Officer and Representative Director Kazuyoshi Kobayashi was the last director to join the board, commencing their role in 2015. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.공시 • Apr 08Corona Corporation to Report Fiscal Year 2022 Results on May 10, 2022Corona Corporation announced that they will report fiscal year 2022 results on May 10, 2022Upcoming Dividend • Mar 23Upcoming dividend of JP¥14.00 per shareEligible shareholders must have bought the stock before 30 March 2022. Payment date: 28 June 2022. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 3.1%. Lower than top quartile of Japanese dividend payers (3.4%). Higher than average of industry peers (1.6%).Reported Earnings • Feb 03Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: JP¥47.58 (down from JP¥52.24 in 3Q 2021). Revenue: JP¥26.4b (down 6.3% from 3Q 2021). Net income: JP¥1.39b (down 9.1% from 3Q 2021). Profit margin: 5.2% (down from 5.4% in 3Q 2021). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings.공시 • Feb 02+ 1 more updateCorona Corporation Provides Dividend for the third Quarter of Fiscal 2022; Provides Dividend Guidance for the Year Ending March 31, 2022Corona Corporation announced dividend for the third quarter of fiscal 2022. The company announced to pay dividend of JPY 14.00 per share for the third quarter of fiscal 2022 against JPY 14.00 per share paid a year ago.The company expects to pay year-end dividend of JPY 14.00 per share for the fiscal 2022 against JPY 14.00 per share paid a year ago.Reported Earnings • Nov 01Second quarter 2022 earnings released: EPS JP¥11.64 (vs JP¥11.63 in 2Q 2021)The company reported a solid second quarter result with improved revenues, although earnings and profit margins were flat. Second quarter 2022 results: Revenue: JP¥20.1b (up 3.1% from 2Q 2021). Net income: JP¥339.0m (flat on 2Q 2021). Profit margin: 1.7% (in line with 2Q 2021). Over the last 3 years on average, earnings per share has fallen by 43% per year but the company’s share price has only fallen by 6% per year, which means it has not declined as severely as earnings.Reported Earnings • Nov 01Second quarter 2022 earnings released: EPS JP¥11.64 (vs JP¥11.63 in 2Q 2021)The company reported a solid second quarter result with improved revenues, although earnings and profit margins were flat. Second quarter 2022 results: Revenue: JP¥20.1b (up 3.1% from 2Q 2021). Net income: JP¥339.0m (flat on 2Q 2021). Profit margin: 1.7% (in line with 2Q 2021). Over the last 3 years on average, earnings per share has fallen by 43% per year but the company’s share price has only fallen by 6% per year, which means it has not declined as severely as earnings.Upcoming Dividend • Sep 22Upcoming dividend of JP¥14.00 per shareEligible shareholders must have bought the stock before 29 September 2021. Payment date: 02 December 2021. Trailing yield: 3.0%. Within top quartile of Japanese dividend payers (3.0%). Higher than average of industry peers (1.4%).Reported Earnings • Aug 03First quarter 2022 earnings released: JP¥4.98 loss per share (vs JP¥16.20 loss in 1Q 2021)The company reported a decent first quarter result with reduced losses and improved control over expenses, although revenues were weaker. First quarter 2022 results: Revenue: JP¥18.1b (down 12% from 1Q 2021). Net loss: JP¥145.0m (loss narrowed 69% from 1Q 2021). Over the last 3 years on average, earnings per share has fallen by 58% per year but the company’s share price has only fallen by 9% per year, which means it has not declined as severely as earnings.Reported Earnings • May 09Full year 2021 earnings released: EPS JP¥21.46 (vs JP¥13.17 in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: JP¥82.2b (up 4.4% from FY 2020). Net income: JP¥626.0m (up 63% from FY 2020). Profit margin: 0.8% (up from 0.5% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 61 percentage points per year, which is a significant difference in performance.공시 • May 08+ 1 more updateCorona Corporation Announces Year-End Dividend for the Fiscal Year Ending March 31, 2021, Payable on June 28, 2021; Provides Dividend Guidance for the Second Quarter and Full Year of Fiscal 2022Corona Corporation announced year-end dividend of JPY 14.00 per share for the fiscal year ending March 31, 2021 against JPY 14.00 per share paid a year ago. The dividend is payable on June 28, 2021. The company expects to pay dividend of JPY 14.00 per share for the second quarter of fiscal 2022 against JPY 14.00 per share paid a year ago. The company expects to pay year-end dividend of JPY 14.00 per share for the fiscal 2022 against JPY 14.00 per share paid a year ago.Upcoming Dividend • Mar 23Upcoming dividend of JP¥14.00 per shareEligible shareholders must have bought the stock before 30 March 2021. Payment date: 26 June 2021. Trailing yield: 2.8%. Within top quartile of Japanese dividend payers (2.7%). Higher than average of industry peers (1.3%).공시 • Mar 04Corona Corporation to Report Fiscal Year 2021 Results on May 07, 2021Corona Corporation announced that they will report fiscal year 2021 results on May 07, 2021Reported Earnings • Feb 03Third quarter 2021 earnings released: EPS JP¥52.24 (vs JP¥51.07 in 3Q 2020)The company reported a solid third quarter result with improved earnings and revenues, although profit margins were weaker. Third quarter 2021 results: Revenue: JP¥28.2b (up 6.3% from 3Q 2020). Net income: JP¥1.52b (up 2.2% from 3Q 2020). Profit margin: 5.4% (down from 5.6% in 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 73% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings.공시 • Dec 05Corona Corporation to Report Q3, 2021 Results on Feb 02, 2021Corona Corporation announced that they will report Q3, 2021 results on Feb 02, 2021공시 • Sep 04Corona Corporation to Report Q2, 2021 Results on Oct 30, 2020Corona Corporation announced that they will report Q2, 2021 results on Oct 30, 2020주주 수익률5909JP Consumer DurablesJP 시장7D0.5%-2.2%-3.1%1Y3.8%12.6%38.2%전체 주주 수익률 보기수익률 대 산업: 5909은 지난 1년 동안 12.6%의 수익을 기록한 JP Consumer Durables 산업보다 저조한 성과를 냈습니다.수익률 대 시장: 5909은 지난 1년 동안 38.2%를 기록한 JP 시장보다 저조한 성과를 냈습니다.주가 변동성Is 5909's price volatile compared to industry and market?5909 volatility5909 Average Weekly Movement4.0%Consumer Durables Industry Average Movement3.9%Market Average Movement5.0%10% most volatile stocks in JP Market9.6%10% least volatile stocks in JP Market2.5%안정적인 주가: 5909는 지난 3개월 동안 JP 시장에 비해 주가 변동성이 크지 않았습니다.시간에 따른 변동성: 5909의 주간 변동성(4%)은 지난 1년 동안 안정적이었습니다.회사 소개설립직원 수CEO웹사이트19372,110Mitsuru Omomowww.corona.co.jp코로나 코퍼레이션은 일본에서 등유 난방기구를 제조 및 판매하는 회사입니다. 주요 제품으로는 등유 선풍기, 휴대용 등유 히터, 제습기 등의 가전제품이 있습니다. 이 회사는 1937년에 설립되었으며 일본 산조에 본사를 두고 있습니다.더 보기Corona Corporation 기초 지표 요약Corona의 순이익과 매출은 시가총액과 어떻게 비교됩니까?5909 기초 통계시가총액JP¥27.49b순이익 (TTM)JP¥991.00m매출 (TTM)JP¥85.34b27.3x주가수익비율(P/E)0.3x주가매출비율(P/S)5909는 고평가되어 있습니까?공정 가치 및 평가 분석 보기순이익 및 매출최근 실적 보고서(TTM)의 주요 수익성 지표5909 손익계산서 (TTM)매출JP¥85.34b매출원가JP¥66.98b총이익JP¥18.36b기타 비용JP¥17.37b순이익JP¥991.00m최근 보고된 실적Mar 31, 2026다음 실적 발표일해당 없음주당순이익(EPS)33.89총이익률21.52%순이익률1.16%부채/자본 비율0%5909의 장기 실적은 어땠습니까?과거 실적 및 비교 보기배당3.0%현재 배당 수익률112%배당 성향5909는 안정적으로 배당을 지급합니까?5909 배당 기록 및 벤치마크 보기다가오는 배당을 받으려면 언제까지 5909를 매수해야 하나요?Corona 배당 일정배당락일Mar 30 2026배당 지급일Jun 25 2026배당락일까지 남은 일수53 days배당 지급일까지 남은 일수34 days5909는 안정적으로 배당을 지급합니까?5909 배당 기록 및 벤치마크 보기View Valuation기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/21 12:27종가2026/05/21 00:00수익2026/03/31연간 수익2026/03/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Corona Corporation는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
Reported Earnings • May 13Full year 2026 earnings released: EPS: JP¥33.90 (vs JP¥37.77 in FY 2025)Full year 2026 results: EPS: JP¥33.90 (down from JP¥37.77 in FY 2025). Revenue: JP¥85.3b (flat on FY 2025). Net income: JP¥991.0m (down 10% from FY 2025). Profit margin: 1.2% (down from 1.3% in FY 2025). Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.
공시 • May 12Corona Corporation, Annual General Meeting, Jun 24, 2026Corona Corporation, Annual General Meeting, Jun 24, 2026.
공시 • May 10Corona Corporation to Report Fiscal Year 2026 Results on May 12, 2026Corona Corporation announced that they will report fiscal year 2026 results on May 12, 2026
Upcoming Dividend • Mar 23Upcoming dividend of JP¥14.00 per shareEligible shareholders must have bought the stock before 30 March 2026. Payment date: 29 June 2026. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 2.9%. Lower than top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (1.6%).
Reported Earnings • Feb 05Third quarter 2026 earnings released: EPS: JP¥60.52 (vs JP¥59.57 in 3Q 2025)Third quarter 2026 results: EPS: JP¥60.52 (up from JP¥59.57 in 3Q 2025). Revenue: JP¥29.0b (flat on 3Q 2025). Net income: JP¥1.77b (up 1.7% from 3Q 2025). Profit margin: 6.1% (up from 6.0% in 3Q 2025). Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.
분석 기사 • Dec 18Corona (TSE:5909) Is Paying Out A Dividend Of ¥14.00The board of Corona Corporation ( TSE:5909 ) has announced that it will pay a dividend on the 29th of June, with...
Reported Earnings • May 13Full year 2026 earnings released: EPS: JP¥33.90 (vs JP¥37.77 in FY 2025)Full year 2026 results: EPS: JP¥33.90 (down from JP¥37.77 in FY 2025). Revenue: JP¥85.3b (flat on FY 2025). Net income: JP¥991.0m (down 10% from FY 2025). Profit margin: 1.2% (down from 1.3% in FY 2025). Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.
공시 • May 12Corona Corporation, Annual General Meeting, Jun 24, 2026Corona Corporation, Annual General Meeting, Jun 24, 2026.
공시 • May 10Corona Corporation to Report Fiscal Year 2026 Results on May 12, 2026Corona Corporation announced that they will report fiscal year 2026 results on May 12, 2026
Upcoming Dividend • Mar 23Upcoming dividend of JP¥14.00 per shareEligible shareholders must have bought the stock before 30 March 2026. Payment date: 29 June 2026. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 2.9%. Lower than top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (1.6%).
Reported Earnings • Feb 05Third quarter 2026 earnings released: EPS: JP¥60.52 (vs JP¥59.57 in 3Q 2025)Third quarter 2026 results: EPS: JP¥60.52 (up from JP¥59.57 in 3Q 2025). Revenue: JP¥29.0b (flat on 3Q 2025). Net income: JP¥1.77b (up 1.7% from 3Q 2025). Profit margin: 6.1% (up from 6.0% in 3Q 2025). Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.
분석 기사 • Dec 18Corona (TSE:5909) Is Paying Out A Dividend Of ¥14.00The board of Corona Corporation ( TSE:5909 ) has announced that it will pay a dividend on the 29th of June, with...
공시 • Dec 17Corona Corporation to Report Q3, 2026 Results on Feb 04, 2026Corona Corporation announced that they will report Q3, 2026 results on Feb 04, 2026
분석 기사 • Dec 04Corona's (TSE:5909) Dividend Will Be ¥14.00Corona Corporation's ( TSE:5909 ) investors are due to receive a payment of ¥14.00 per share on 29th of June. This...
Declared Dividend • Dec 04First half dividend of JP¥14.00 announcedDividend of JP¥14.00 is the same as last year. Ex-date: 30th March 2026 Payment date: 29th June 2026 Dividend yield will be 2.9%, which is higher than the industry average of 1.6%. Sustainability & Growth Dividend is not covered by earnings (117% earnings payout ratio) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. The company's earnings per share (EPS) would need to grow by 29% to bring the payout ratio under control, which is more than the 14% EPS growth achieved over the last 5 years.
Reported Earnings • Oct 31Second quarter 2026 earnings released: EPS: JP¥9.34 (vs JP¥11.30 in 2Q 2025)Second quarter 2026 results: EPS: JP¥9.34 (down from JP¥11.30 in 2Q 2025). Revenue: JP¥21.3b (flat on 2Q 2025). Net income: JP¥273.0m (down 17% from 2Q 2025). Profit margin: 1.3% (down from 1.6% in 2Q 2025). Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings.
Upcoming Dividend • Sep 22Upcoming dividend of JP¥14.00 per shareEligible shareholders must have bought the stock before 29 September 2025. Payment date: 03 December 2025. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 2.9%. Lower than top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (1.4%).
분석 기사 • Sep 19Corona (TSE:5909) Has Announced A Dividend Of ¥14.00Corona Corporation ( TSE:5909 ) will pay a dividend of ¥14.00 on the 3rd of December. This makes the dividend yield...
분석 기사 • Sep 03Corona's (TSE:5909) Dividend Will Be ¥14.00Corona Corporation ( TSE:5909 ) will pay a dividend of ¥14.00 on the 3rd of December. The dividend yield will be 3.0...
공시 • Sep 02Corona Corporation to Report Q2, 2026 Results on Oct 30, 2025Corona Corporation announced that they will report Q2, 2026 results on Oct 30, 2025
New Risk • Aug 06New major risk - Dividend sustainabilityThe dividend is not well covered by earnings and cash flows. Payout ratio: 108% The company is paying a dividend despite having no free cash flows. Dividend yield: 2.9% This is considered a major risk. Companies that pay out too much of their earnings and cash flows are at risk of having to reduce or cut their dividend in future. If earnings or cash flows stagnate or fall, then there may not be enough to maintain the same dividend. Or in extreme cases, companies may opt to dig into capital reserves or take on debt to maintain the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Payout ratio: 108% Paying a dividend despite having no free cash flows. Minor Risk Profit margins are more than 30% lower than last year (0.9% net profit margin).
Reported Earnings • Jul 31First quarter 2026 earnings released: JP¥18.21 loss per share (vs JP¥6.44 loss in 1Q 2025)First quarter 2026 results: JP¥18.21 loss per share (further deteriorated from JP¥6.44 loss in 1Q 2025). Revenue: JP¥18.9b (flat on 1Q 2025). Net loss: JP¥532.0m (loss widened 183% from 1Q 2025). Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings.
분석 기사 • Jul 24Corona's (TSE:5909) Dividend Will Be ¥14.00The board of Corona Corporation ( TSE:5909 ) has announced that it will pay a dividend of ¥14.00 per share on the 3rd...
분석 기사 • Jul 10Corona (TSE:5909) Is Due To Pay A Dividend Of ¥14.00Corona Corporation ( TSE:5909 ) has announced that it will pay a dividend of ¥14.00 per share on the 3rd of December...
Declared Dividend • Jul 09Final dividend of JP¥14.00 announcedDividend of JP¥14.00 is the same as last year. Ex-date: 29th September 2025 Payment date: 3rd December 2025 Dividend yield will be 3.0%, which is higher than the industry average of 1.6%. Sustainability & Growth Dividend is covered by earnings (72% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 23% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
공시 • Jun 27Corona Corporation to Report Q1, 2026 Results on Jul 30, 2025Corona Corporation announced that they will report Q1, 2026 results on Jul 30, 2025
Reported Earnings • May 10Full year 2025 earnings released: EPS: JP¥37.77 (vs JP¥44.74 in FY 2024)Full year 2025 results: EPS: JP¥37.77 (down from JP¥44.74 in FY 2024). Revenue: JP¥85.2b (up 3.9% from FY 2024). Net income: JP¥1.10b (down 16% from FY 2024). Profit margin: 1.3% (down from 1.6% in FY 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 2% per year whereas the company’s share price has increased by 4% per year.
공시 • May 09Corona Corporation, Annual General Meeting, Jun 26, 2025Corona Corporation, Annual General Meeting, Jun 26, 2025.
분석 기사 • Mar 22Corona (TSE:5909) Has Affirmed Its Dividend Of ¥14.00Corona Corporation ( TSE:5909 ) has announced that it will pay a dividend of ¥14.00 per share on the 26th of June...
공시 • Mar 22Corona Corporation to Report Fiscal Year 2025 Results on May 09, 2025Corona Corporation announced that they will report fiscal year 2025 results on May 09, 2025
Upcoming Dividend • Mar 21Upcoming dividend of JP¥14.00 per shareEligible shareholders must have bought the stock before 28 March 2025. Payment date: 26 June 2025. Payout ratio is a comfortable 72% but the company is not cash flow positive. Trailing yield: 2.8%. Lower than top quartile of Japanese dividend payers (3.7%). Higher than average of industry peers (1.5%).
분석 기사 • Feb 10Corona (TSE:5909) Is Due To Pay A Dividend Of ¥14.00The board of Corona Corporation ( TSE:5909 ) has announced that it will pay a dividend on the 26th of June, with...
Reported Earnings • Feb 06Third quarter 2025 earnings released: EPS: JP¥59.57 (vs JP¥69.50 in 3Q 2024)Third quarter 2025 results: EPS: JP¥59.57 (down from JP¥69.50 in 3Q 2024). Revenue: JP¥29.0b (down 3.8% from 3Q 2024). Net income: JP¥1.74b (down 14% from 3Q 2024). Profit margin: 6.0% (down from 6.7% in 3Q 2024). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.
분석 기사 • Dec 20Corona (TSE:5909) Has Announced A Dividend Of ¥14.00Corona Corporation ( TSE:5909 ) has announced that it will pay a dividend of ¥14.00 per share on the 26th of June. This...
공시 • Dec 20Corona Corporation to Report Q3, 2025 Results on Feb 04, 2025Corona Corporation announced that they will report Q3, 2025 results on Feb 04, 2025
분석 기사 • Dec 04Corona (TSE:5909) Is Due To Pay A Dividend Of ¥14.00Corona Corporation's ( TSE:5909 ) investors are due to receive a payment of ¥14.00 per share on 26th of June. The...
Declared Dividend • Dec 04First half dividend of JP¥14.00 announcedDividend of JP¥14.00 is the same as last year. Ex-date: 28th March 2025 Payment date: 26th June 2025 Dividend yield will be 2.9%, which is higher than the industry average of 1.6%. Sustainability & Growth Dividend is covered by earnings (29% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 4.3% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
Reported Earnings • Nov 01Second quarter 2025 earnings released: EPS: JP¥11.30 (vs JP¥7.80 in 2Q 2024)Second quarter 2025 results: EPS: JP¥11.30 (up from JP¥7.80 in 2Q 2024). Revenue: JP¥21.3b (up 10.0% from 2Q 2024). Net income: JP¥330.0m (up 45% from 2Q 2024). Profit margin: 1.6% (up from 1.2% in 2Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.
분석 기사 • Sep 24Corona (TSE:5909) Has Announced A Dividend Of ¥14.00Corona Corporation's ( TSE:5909 ) investors are due to receive a payment of ¥14.00 per share on 4th of December. The...
Upcoming Dividend • Sep 20Upcoming dividend of JP¥14.00 per shareEligible shareholders must have bought the stock before 27 September 2024. Payment date: 04 December 2024. Payout ratio is a comfortable 61% but the company is not cash flow positive. Trailing yield: 2.9%. Lower than top quartile of Japanese dividend payers (3.8%). Higher than average of industry peers (1.8%).
분석 기사 • Aug 29Corona (TSE:5909) Will Pay A Dividend Of ¥14.00The board of Corona Corporation ( TSE:5909 ) has announced that it will pay a dividend on the 4th of December, with...
공시 • Aug 28Corona Corporation to Report Q2, 2025 Results on Oct 30, 2024Corona Corporation announced that they will report Q2, 2025 results on Oct 30, 2024
분석 기사 • Aug 09Corona (TSE:5909) Is Due To Pay A Dividend Of ¥14.00The board of Corona Corporation ( TSE:5909 ) has announced that it will pay a dividend of ¥14.00 per share on the 4th...
Reported Earnings • Aug 01First quarter 2025 earnings released: JP¥6.44 loss per share (vs JP¥7.27 loss in 1Q 2024)First quarter 2025 results: JP¥6.44 loss per share (improved from JP¥7.27 loss in 1Q 2024). Revenue: JP¥18.9b (up 5.5% from 1Q 2024). Net loss: JP¥188.0m (loss narrowed 11% from 1Q 2024). Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth.
공시 • Jul 30+ 1 more updateCorona Corporation Provides Consolidated Earnings Guidance for Period Ending September 2024 and for Year Ending March 2025Corona Corporation provided consolidated earnings guidance for period ending September 2024 and for year ending March 2025. For the period, the company expected net sales of JPY 39,200 million, operating loss of JPY 500 million, loss attributable to owners of parent of JPY 300 million, Basic loss per share of JPY 10.28 per basic share. For the year 2025, the company expected net sales of JPY 85,000 million, operating profit of JPY 1,300 million, profit attributable to owners of parent of JPY 1,200 million, Basic earnings per share of JPY 41.10 per basic share.
분석 기사 • Jul 26Corona (TSE:5909) Has Announced A Dividend Of ¥14.00The board of Corona Corporation ( TSE:5909 ) has announced that it will pay a dividend on the 4th of December, with...
분석 기사 • Jul 12Corona's (TSE:5909) Dividend Will Be ¥14.00Corona Corporation's ( TSE:5909 ) investors are due to receive a payment of ¥14.00 per share on 4th of December. The...
Declared Dividend • Jul 11Final dividend of JP¥14.00 announcedDividend of JP¥14.00 is the same as last year. Ex-date: 27th September 2024 Payment date: 4th December 2024 Dividend yield will be 2.9%, which is higher than the industry average of 1.6%. Sustainability & Growth Dividend is not covered by earnings (102% earnings payout ratio) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to grow by 13% to bring the payout ratio under control, which is more than the 1.0% EPS growth achieved over the last 5 years.
공시 • Jun 27Corona Corporation to Report Q1, 2025 Results on Jul 30, 2024Corona Corporation announced that they will report Q1, 2025 results on Jul 30, 2024
Reported Earnings • May 12Full year 2024 earnings released: EPS: JP¥44.74 (vs JP¥50.81 in FY 2023)Full year 2024 results: EPS: JP¥44.74 (down from JP¥50.81 in FY 2023). Revenue: JP¥82.0b (down 3.9% from FY 2023). Net income: JP¥1.31b (down 12% from FY 2023). Profit margin: 1.6% (down from 1.7% in FY 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.
공시 • May 12Corona Corporation, Annual General Meeting, Jun 25, 2024Corona Corporation, Annual General Meeting, Jun 25, 2024.
분석 기사 • Mar 25Corona (TSE:5909) Has Announced A Dividend Of ¥14.00Corona Corporation ( TSE:5909 ) has announced that it will pay a dividend of ¥14.00 per share on the 1st of July. This...
공시 • Mar 23Corona Corporation to Report Fiscal Year 2024 Results on May 10, 2024Corona Corporation announced that they will report fiscal year 2024 results on May 10, 2024
Upcoming Dividend • Mar 21Upcoming dividend of JP¥14.00 per shareEligible shareholders must have bought the stock before 28 March 2024. Payment date: 01 July 2024. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 2.8%. Lower than top quartile of Japanese dividend payers (3.2%). Higher than average of industry peers (1.6%).
Reported Earnings • Feb 04Third quarter 2024 earnings released: EPS: JP¥69.50 (vs JP¥65.42 in 3Q 2023)Third quarter 2024 results: EPS: JP¥69.50 (up from JP¥65.42 in 3Q 2023). Revenue: JP¥30.1b (up 2.0% from 3Q 2023). Net income: JP¥2.03b (up 6.3% from 3Q 2023). Profit margin: 6.7% (up from 6.5% in 3Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.
공시 • Feb 02+ 1 more updateCorona Corporation Provides Dividend Guidance for the Full Year Ending March 31, 2024Corona Corporation provided dividend guidance of JPY 14.00 for the full year ending March 31, 2024.
공시 • Dec 16Corona Corporation to Report Q3, 2024 Results on Feb 02, 2024Corona Corporation announced that they will report Q3, 2024 results on Feb 02, 2024
공시 • Nov 02Corona Corporation (TSE:5909) announces an Equity Buyback for 80,000 shares, representing 0.27% for ¥75 million.Corona Corporation (TSE:5909) announces an share repurchase program. Under the program the company will repurchase 80,000 shares, representing 0.27% of its issued share capital, for ¥75 million. The purpose of the program is to enable the implementation of a flexible capital policy in response to changes in the business environment. The program is valid till November 16, 2023. As of October 31, 2023, the company had 29,226,249 issued shares (excluding treasury stock) and 116,205 shares in treasury.
Buying Opportunity • Oct 04Now 21% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be JP¥1,149, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 56%.
Upcoming Dividend • Sep 21Upcoming dividend of JP¥14.00 per share at 3.0% yieldEligible shareholders must have bought the stock before 28 September 2023. Payment date: 04 December 2023. Payout ratio is a comfortable 62% and this is well supported by cash flows. Trailing yield: 3.0%. Lower than top quartile of Japanese dividend payers (3.3%). Higher than average of industry peers (1.6%).
공시 • Sep 16Corona Corporation to Report Q2, 2024 Results on Oct 31, 2023Corona Corporation announced that they will report Q2, 2024 results on Oct 31, 2023
Reported Earnings • Jul 29First quarter 2024 earnings released: JP¥7.27 loss per share (vs JP¥1.72 loss in 1Q 2023)First quarter 2024 results: JP¥7.27 loss per share (further deteriorated from JP¥1.72 loss in 1Q 2023). Revenue: JP¥17.9b (down 7.5% from 1Q 2023). Net loss: JP¥212.0m (loss widened 324% from 1Q 2023). Over the last 3 years on average, earnings per share has increased by 56% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.
공시 • Jun 28Corona Corporation to Report Q1, 2024 Results on Jul 28, 2023Corona Corporation announced that they will report Q1, 2024 results on Jul 28, 2023
Reported Earnings • May 12Full year 2023 earnings released: EPS: JP¥50.81 (vs JP¥32.25 in FY 2022)Full year 2023 results: EPS: JP¥50.81 (up from JP¥32.25 in FY 2022). Revenue: JP¥85.3b (up 8.5% from FY 2022). Net income: JP¥1.48b (up 58% from FY 2022). Profit margin: 1.7% (up from 1.2% in FY 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 60% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.
공시 • May 11Corona Corporation, Annual General Meeting, Jun 28, 2023Corona Corporation, Annual General Meeting, Jun 28, 2023.
Upcoming Dividend • Mar 23Upcoming dividend of JP¥14.00 per share at 3.1% yieldEligible shareholders must have bought the stock before 30 March 2023. Payment date: 29 June 2023. Payout ratio is a comfortable 24% and this is well supported by cash flows. Trailing yield: 3.1%. Lower than top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (1.8%).
Reported Earnings • Feb 04Third quarter 2023 earnings released: EPS: JP¥65.42 (vs JP¥47.58 in 3Q 2022)Third quarter 2023 results: EPS: JP¥65.42 (up from JP¥47.58 in 3Q 2022). Revenue: JP¥29.5b (up 12% from 3Q 2022). Net income: JP¥1.91b (up 38% from 3Q 2022). Profit margin: 6.5% (up from 5.2% in 3Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.
공시 • Dec 08Corona Corporation to Report Q3, 2023 Results on Feb 03, 2023Corona Corporation announced that they will report Q3, 2023 results on Feb 03, 2023
Board Change • Nov 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 9 highly experienced directors. No independent directors (9 non-independent directors). Vice-President, Executive Officer and Representative Director Kazuyoshi Kobayashi was the last director to join the board, commencing their role in 2015. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Reported Earnings • Nov 03Second quarter 2023 earnings released: EPS: JP¥15.77 (vs JP¥11.64 in 2Q 2022)Second quarter 2023 results: EPS: JP¥15.77 (up from JP¥11.64 in 2Q 2022). Revenue: JP¥20.6b (up 2.8% from 2Q 2022). Net income: JP¥460.0m (up 36% from 2Q 2022). Profit margin: 2.2% (up from 1.7% in 2Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.
공시 • Nov 02Corona Corporation Provides Consolidated Earnings Guidance for Year Ending March 2023Corona Corporation provided consolidated earnings guidance for year ending March 2023. For the period, the company expected net sales of JPY 82,700 million, operating profit of JPY 1,200 million, profit attributable to owners of parent of JPY 1,000 million, Basic earnings per share of JPY 34.34 per basic share.
공시 • Nov 01Corona Corporation Announces Dividend for the Second Quarter of Fiscal Year Ending March 2023, Payable on December 2, 2022; Announces Dividend Guidance for Year Ending March 2023Corona Corporation announced dividend of JPY 14 per share for the second quarter of fiscal year ending March 2023. Dividend payable date (as planned) is December 2, 2022. For the year the company expects to pay the dividend of JPY 14 per share.
Upcoming Dividend • Sep 22Upcoming dividend of JP¥14.00 per shareEligible shareholders must have bought the stock before 29 September 2022. Payment date: 02 December 2022. Payout ratio is on the higher end at 79%, however this is supported by cash flows. Trailing yield: 3.3%. Lower than top quartile of Japanese dividend payers (3.7%). Higher than average of industry peers (1.9%).
공시 • Sep 01Corona Corporation to Report Q2, 2023 Results on Nov 01, 2022Corona Corporation announced that they will report Q2, 2023 results on Nov 01, 2022
Reported Earnings • Jul 31First quarter 2023 earnings released: JP¥1.72 loss per share (vs JP¥4.98 loss in 1Q 2022)First quarter 2023 results: JP¥1.72 loss per share (up from JP¥4.98 loss in 1Q 2022). Revenue: JP¥19.3b (up 6.9% from 1Q 2022). Net loss: JP¥50.0m (loss narrowed 66% from 1Q 2022). Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings.
공시 • Jul 29+ 1 more updateCorona Corporation Announces Dividend for the Second Quarter Ended September 30, 2022; Provides Dividend Guidance for the Year Ending December 31, 2022Corona Corporation announced a dividend of ¥14.00 per share for the second quarter ended September 30, 2022, against ¥14.00 per share paid a year ago.For the year ending December 31, 2022, the company expects a dividend of ¥14.00 per share against ¥14.00 per share paid a year ago.
공시 • Jun 29Corona Corporation to Report Q1, 2023 Results on Jul 29, 2022Corona Corporation announced that they will report Q1, 2023 results on Jul 29, 2022
공시 • May 12+ 1 more updateCorona Corporation Announces Dividend for the Year Ended March 2022, Payable on June 29, 2022; Provides Dividend Guidance for the Second Quarter of Fiscal Year March 2023 and Year End March 2023Corona Corporation announced dividend of JPY 14.00 per share for the year ended March 2022 as compared to paid dividend of JPY 14.00 per share a year ago. Dividend payable date (as planned) June 29, 2022. For the second quarter of fiscal year March 2023, the company expected dividend to be JPY 14.00 per share.For the year end March 2023, the company expected dividend to be JPY 14.00 per share.
Reported Earnings • May 11Full year 2022 earnings released: EPS: JP¥32.25 (vs JP¥21.46 in FY 2021)Full year 2022 results: EPS: JP¥32.25 (up from JP¥21.46 in FY 2021). Revenue: JP¥78.6b (down 4.3% from FY 2021). Net income: JP¥939.0m (up 50% from FY 2021). Profit margin: 1.2% (up from 0.8% in FY 2021). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 9% per year whereas the company’s share price has fallen by 6% per year.
공시 • May 10Corona Corporation, Annual General Meeting, Jun 28, 2022Corona Corporation, Annual General Meeting, Jun 28, 2022.
Board Change • Apr 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 8 highly experienced directors. No independent directors (8 non-independent directors). Vice-President, Executive Officer and Representative Director Kazuyoshi Kobayashi was the last director to join the board, commencing their role in 2015. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
공시 • Apr 08Corona Corporation to Report Fiscal Year 2022 Results on May 10, 2022Corona Corporation announced that they will report fiscal year 2022 results on May 10, 2022
Upcoming Dividend • Mar 23Upcoming dividend of JP¥14.00 per shareEligible shareholders must have bought the stock before 30 March 2022. Payment date: 28 June 2022. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 3.1%. Lower than top quartile of Japanese dividend payers (3.4%). Higher than average of industry peers (1.6%).
Reported Earnings • Feb 03Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: JP¥47.58 (down from JP¥52.24 in 3Q 2021). Revenue: JP¥26.4b (down 6.3% from 3Q 2021). Net income: JP¥1.39b (down 9.1% from 3Q 2021). Profit margin: 5.2% (down from 5.4% in 3Q 2021). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings.
공시 • Feb 02+ 1 more updateCorona Corporation Provides Dividend for the third Quarter of Fiscal 2022; Provides Dividend Guidance for the Year Ending March 31, 2022Corona Corporation announced dividend for the third quarter of fiscal 2022. The company announced to pay dividend of JPY 14.00 per share for the third quarter of fiscal 2022 against JPY 14.00 per share paid a year ago.The company expects to pay year-end dividend of JPY 14.00 per share for the fiscal 2022 against JPY 14.00 per share paid a year ago.
Reported Earnings • Nov 01Second quarter 2022 earnings released: EPS JP¥11.64 (vs JP¥11.63 in 2Q 2021)The company reported a solid second quarter result with improved revenues, although earnings and profit margins were flat. Second quarter 2022 results: Revenue: JP¥20.1b (up 3.1% from 2Q 2021). Net income: JP¥339.0m (flat on 2Q 2021). Profit margin: 1.7% (in line with 2Q 2021). Over the last 3 years on average, earnings per share has fallen by 43% per year but the company’s share price has only fallen by 6% per year, which means it has not declined as severely as earnings.
Reported Earnings • Nov 01Second quarter 2022 earnings released: EPS JP¥11.64 (vs JP¥11.63 in 2Q 2021)The company reported a solid second quarter result with improved revenues, although earnings and profit margins were flat. Second quarter 2022 results: Revenue: JP¥20.1b (up 3.1% from 2Q 2021). Net income: JP¥339.0m (flat on 2Q 2021). Profit margin: 1.7% (in line with 2Q 2021). Over the last 3 years on average, earnings per share has fallen by 43% per year but the company’s share price has only fallen by 6% per year, which means it has not declined as severely as earnings.
Upcoming Dividend • Sep 22Upcoming dividend of JP¥14.00 per shareEligible shareholders must have bought the stock before 29 September 2021. Payment date: 02 December 2021. Trailing yield: 3.0%. Within top quartile of Japanese dividend payers (3.0%). Higher than average of industry peers (1.4%).
Reported Earnings • Aug 03First quarter 2022 earnings released: JP¥4.98 loss per share (vs JP¥16.20 loss in 1Q 2021)The company reported a decent first quarter result with reduced losses and improved control over expenses, although revenues were weaker. First quarter 2022 results: Revenue: JP¥18.1b (down 12% from 1Q 2021). Net loss: JP¥145.0m (loss narrowed 69% from 1Q 2021). Over the last 3 years on average, earnings per share has fallen by 58% per year but the company’s share price has only fallen by 9% per year, which means it has not declined as severely as earnings.
Reported Earnings • May 09Full year 2021 earnings released: EPS JP¥21.46 (vs JP¥13.17 in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: JP¥82.2b (up 4.4% from FY 2020). Net income: JP¥626.0m (up 63% from FY 2020). Profit margin: 0.8% (up from 0.5% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 61 percentage points per year, which is a significant difference in performance.
공시 • May 08+ 1 more updateCorona Corporation Announces Year-End Dividend for the Fiscal Year Ending March 31, 2021, Payable on June 28, 2021; Provides Dividend Guidance for the Second Quarter and Full Year of Fiscal 2022Corona Corporation announced year-end dividend of JPY 14.00 per share for the fiscal year ending March 31, 2021 against JPY 14.00 per share paid a year ago. The dividend is payable on June 28, 2021. The company expects to pay dividend of JPY 14.00 per share for the second quarter of fiscal 2022 against JPY 14.00 per share paid a year ago. The company expects to pay year-end dividend of JPY 14.00 per share for the fiscal 2022 against JPY 14.00 per share paid a year ago.
Upcoming Dividend • Mar 23Upcoming dividend of JP¥14.00 per shareEligible shareholders must have bought the stock before 30 March 2021. Payment date: 26 June 2021. Trailing yield: 2.8%. Within top quartile of Japanese dividend payers (2.7%). Higher than average of industry peers (1.3%).
공시 • Mar 04Corona Corporation to Report Fiscal Year 2021 Results on May 07, 2021Corona Corporation announced that they will report fiscal year 2021 results on May 07, 2021
Reported Earnings • Feb 03Third quarter 2021 earnings released: EPS JP¥52.24 (vs JP¥51.07 in 3Q 2020)The company reported a solid third quarter result with improved earnings and revenues, although profit margins were weaker. Third quarter 2021 results: Revenue: JP¥28.2b (up 6.3% from 3Q 2020). Net income: JP¥1.52b (up 2.2% from 3Q 2020). Profit margin: 5.4% (down from 5.6% in 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 73% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings.
공시 • Dec 05Corona Corporation to Report Q3, 2021 Results on Feb 02, 2021Corona Corporation announced that they will report Q3, 2021 results on Feb 02, 2021
공시 • Sep 04Corona Corporation to Report Q2, 2021 Results on Oct 30, 2020Corona Corporation announced that they will report Q2, 2021 results on Oct 30, 2020
